Wound Care Research: How Private Practices Can Participate

Why Wound Care Research Needs Private Practices

Wound care research has historically been concentrated in academic medical centers and large health systems. This creates a significant gap. The majority of wound care in the United States is delivered in private practices, mobile clinics, and outpatient settings, yet these environments are underrepresented in the evidence base that shapes treatment guidelines, payer policies, and product approvals.

Private wound care practices see patient populations, treatment patterns, and operational realities that academic centers do not. Research conducted exclusively in teaching hospitals may not reflect outcomes achievable in community settings. When private practices participate in wound care research, the evidence becomes more generalizable, more applicable, and ultimately more useful for the clinicians who deliver most of the care.

Participating in research also benefits the practice directly. It builds clinical credibility, attracts referrals from physicians who value evidence-based partners, and can generate revenue through industry-sponsored trials.

Research Opportunities for Non-Academic Practices

Private practices can engage in research at multiple levels of complexity, from simple outcomes tracking to formal clinical trials.

Retrospective Chart Reviews

The lowest-barrier entry point is retrospective analysis of your own clinical data. Every wound care practice generates data on healing rates, time to closure, treatment modalities used, complication rates, and cost per episode. Structuring this data for analysis requires only a clear research question, a defined patient cohort, and consistent documentation practices.

Examples of retrospective questions a private practice can answer:

What is the median time to closure for diabetic foot ulcers treated with collagen dressings versus foam dressings in your patient population?
How does the addition of cellular and tissue-based products affect healing rates for venous leg ulcers that fail four weeks of standard compression therapy?
What is the denial rate for debridement codes when documentation includes standardized wound measurement versus narrative descriptions?

Retrospective studies require IRB review but often qualify for expedited review or exemption because they involve existing data with no prospective patient intervention.

Prospective Quality Improvement Studies

Quality improvement (QI) projects sit between retrospective analysis and formal clinical trials. A QI study implements a practice change and measures outcomes before and after the intervention. Wound care QI projects might evaluate new assessment protocols, documentation workflows, or practice analytics approaches that improve healing outcomes or reduce costs.

Many QI projects do not require full IRB review under the Common Rule, though practices should confirm this with their institutional or independent IRB. The distinction between QI and research can be nuanced, and err on the side of seeking IRB guidance.

Industry-Sponsored Clinical Trials

Skin substitute manufacturers, advanced dressing companies, and NPWT device makers regularly need clinical trial sites. Private wound care practices are attractive partners because they control their referral pipelines, maintain consistent treatment protocols, and can recruit patients efficiently.

Participating as a trial site typically requires:

An identified principal investigator (PI) with appropriate credentials
IRB approval through a central or independent IRB (the sponsor usually facilitates this)
Good Clinical Practice (GCP) training for all study staff
A dedicated study coordinator or a clinician willing to manage enrollment, data collection, and adverse event reporting
Adequate patient volume for the target wound type

Industry sponsors compensate trial sites on a per-patient basis, typically between $2,000 and $8,000 per enrolled patient depending on the study complexity and visit schedule. This revenue can be meaningful for a private practice.

IRB Considerations for Private Practices

Understanding IRB Requirements

The Institutional Review Board (IRB) is the regulatory body that reviews research involving human subjects to ensure ethical protections. Academic medical centers have internal IRBs, but private practices typically use independent or commercial IRBs.

Several independent IRBs serve community and private practice researchers:

WCG IRB (formerly Western IRB) — the largest independent IRB in the US
Advarra — widely used for industry-sponsored multi-site trials
Sterling IRB — serves smaller practices and independent investigators

IRB review costs range from $1,500 to $5,000 for an initial protocol review, with annual renewal fees. Industry sponsors cover these costs for sponsored trials. For investigator-initiated research, the practice bears the expense.

HIPAA and Data De-identification

Any research involving patient data must comply with HIPAA. For retrospective studies, de-identifying data before analysis is often the simplest path. The HIPAA Safe Harbor method requires removing 18 categories of identifiers. For prospective studies, patients sign informed consent documents that authorize the use of their protected health information for research purposes.

From Data to Publication

Research is only valuable if it reaches the professional community. Private practice researchers can publish findings through several channels.

Peer-Reviewed Journals

Wound care journals welcome well-designed studies from community settings. Journals that regularly publish private practice research include Advances in Skin & Wound Care, Ostomy Wound Management, and the Journal of Wound Care. Start with retrospective studies and QI projects before attempting to publish trial results, which require more rigorous methodology.

Conference Presentations

Presenting at wound care conferences such as SAWC, WOCN, or WHS is an excellent stepping stone to publication. Abstract submissions for poster presentations have lower acceptance barriers than oral presentations, and the feedback from conference attendees often strengthens the manuscript for journal submission. Consider building your wound care certification credentials alongside your research portfolio, as both reinforce professional credibility.

Case Series and Practice Reports

If your data set is too small for a formal study, consider publishing a case series. A well-documented series of five to ten patients with a consistent treatment protocol and clear outcomes data contributes meaningfully to the wound care literature, especially for rare wound types or novel treatment combinations.

Key Takeaways

Private wound care practices are underrepresented in research despite delivering the majority of wound care in the US, and their participation makes evidence more generalizable to real-world settings
Retrospective chart reviews are the lowest-barrier entry point, requiring only a clear research question, a defined cohort, and consistent documentation, and often qualifying for expedited IRB review
Industry-sponsored clinical trials compensate participating sites between $2,000 and $8,000 per enrolled patient, making research participation a potential revenue stream for private practices
Independent IRBs such as WCG and Advarra serve private practice researchers who lack institutional review boards, with initial review costs between $1,500 and $5,000
Publication pathways include peer-reviewed wound care journals, conference poster presentations, and case series, all of which build practice credibility and attract evidence-minded referral partners